微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 4.72% | 9.26% | 33.33% | 60/138 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.54% | 61.64% | 158.39% | 48/138 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.37% | 92.96% | -76.38% | 60/138 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 5.8% | 109.39% | 34.26% | 56/138 | 3.05% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 4.32% | 254.1% | 97.26% | 64/138 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 2.19% | 3028.57% | 208.45% | 77/138 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.71% | 191.03% | -74.37% | 81/138 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.77% | -61.63% | 127.05% | 86/138 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 1.22% | -85.44% | 1642.86% | 100/138 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.07% | -98.96% | 108.97% | 112/138 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | -0.78% | -118.93% | -110.8% | 114/138 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 7.22% | -63.16% | -13.84% | 79/138 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 8.38% | -51.7% | 25.07% | 64/138 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.7% | -42.78% | 62.62% | 56/138 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 4.12% | -29.57% | -78.98% | 35/138 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 19.6% | 30.67% | 12.97% | 40/138 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 17.35% | -1.53% | 48.16% | 33/138 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 11.71% | -19.9% | 100.17% | 40/138 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 5.85% | 7.93% | -61% | 30/138 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 15% | -14.58% | -14.87% | 63/138 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 17.62% | 43.14% | 20.52% | 29/138 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 14.62% | 121.18% | 169.74% | 30/138 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 5.42% | 502.22% | -69.13% | 17/138 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 17.56% | -20.65% | 42.65% | 48/138 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 12.31% | 2% | 86.23% | 22/138 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 6.61% | 1.23% | 634.44% | 28/138 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.9% | 2% | -95.93% | 44/138 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 22.13% | 8.91% | 8.91% | 25/138 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2017-12-31 | 20.32% | 28.45% | 211.18% | 25/138 | 13.76% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2017-06-30 | 6.53% | 116.94% | -58.72% | 26/138 | 5.88% | 明德生物 | 14.54% | 行业排名> |
| 2016-12-31 | 15.82% | 59.48% | 425.58% | 33/138 | 16.11% | 迈瑞医疗 | 11% | 行业排名> |
| 2016-06-30 | 3.01% | 2% | -69.66% | 38/138 | 6.24% | 安旭生物 | 59.22% | 行业排名> |